date,title,source
Nov-14-18,Pulmatrix Reports Q3 2018 Results,PR Newswire
Nov-15-18,"Pulmatrix to Present Results from the Pulmazole (PUR1900) Phase 1/1b Study at the 2018 Annual Scientific Meeting of the American College of Allergy, Asthma, and Immunology",PR Newswire
Nov-21-18,Pulmatrix Announces Positive Final Results from the Phase 1/1b Clinical Trial of Pulmazole - an Inhaled Dry-Powder iSPERSE Formulation of Itraconazole,PR Newswire
Nov-29-18,Pulmatrix Announces $3.0 Million Registered Direct Offering,PR Newswire
Jan-28-19,"Pulmatrix, Inc. Announces Proposed Public Offering of Common Stock",PR Newswire
Jan-30-19,"Pulmatrix, Inc. Announces Pricing of Public Offering of Common Stock",PR Newswire
Jan-30-19,"Pulmatrix, Inc. Announces Proposed Public Offering of Common Stock",PR Newswire
Jan-31-19,"Pulmatrix, Inc. Announces Closing of Public Offering of Common Stock",PR Newswire
Feb-05-19,"Pulmatrix, Inc. Announces 1-for-10 Reverse Stock Split",PR Newswire
Feb-05-19,"Pulmatrix, Inc. Announces Closing of Public Offering of Common Stock",PR Newswire
Feb-06-19,4 Biotech Stocks Making Moves on Wednesday (2/6/19),ACCESSWIRE
Feb-06-19,"Pulmatrix, Inc. Announces Termination of Planned Offering Pursuant to Registration Statement on Form S-1",PR Newswire
Feb-07-19,Pulmatrix Receives IND Approval for Pulmazole Phase 2 Clinical Study,PR Newswire
Feb-08-19,"Pulmatrix, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market",PR Newswire
Feb-12-19,Pulmatrix Receives Five Patents Supporting Claims for their Novel Inhaled Narrow Spectrum Kinase Inhibitor Programs,PR Newswire
Feb-19-19,Pulmatrix Reports 2018 Financial Results; Provides 2019 Outlook on Pulmonary Disease Pipeline,PR Newswire
Mar-08-19,These Four Tech Stocks Could Set The Pace On Friday,ACCESSWIRE
Mar-12-19,Pulmatrix Regains NASDAQ Compliance,PR Newswire
Mar-14-19,Pulmatrix to Participate in Upcoming Investor Conferences,PR Newswire
Apr-01-19,"Pulmatrix's stock rockets after deal with Cipla Technologies to develop, commercialize asthma treatment",MarketWatch
Apr-01-19,Pulmatrix Enters Into Binding Term Sheet with Cipla Technologies LLC for the Development and Commercialization of Pulmazole,PR Newswire
Apr-03-19,"Pulmatrix, Inc. Announces Pricing of $14.4 Million Upsized Public Offering",PR Newswire
Apr-08-19,"Pulmatrix, Inc. Announces Closing of $16.6 Million Upsized Public Offering",PR Newswire
Apr-15-19,Pulmatrix and Cipla Technologies LLC enter into Definitive Agreement for the Development and Commercialization of Pulmazole,PR Newswire
May-15-19,Pulmatrix Reports Q1 2019 Results,PR Newswire
May-16-19,Pulmatrix Announces Leadership Change,PR Newswire
Jun-06-19,Bet on 5 Top Stocks With Rising P/E,Zacks
Jun-07-19,"Zacks.com featured highlights include: HP, Party City, AbbVie, OncoSec Medical and Pulmatrix",Zacks
